Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. - Wikidata - awgldk - TriplyDB

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

http://www.wikidata.org/entity/Q37438142

about

Role of exosomes/microvesicles in the nervous system and use in emerging therapies Microvesicles: mediators of extracellular communication during cancer progression Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy Microparticles as Biomarkers of Blood Coagulation in Cancer Platelets, coagulation and fibrinolysis in breast cancer progression Clinical significance of procoagulant microparticles Venous thromboembolism in cancer patients: an underestimated major health problem Biomolecular markers of cancer-associated thromboembolism Activation of blood coagulation in cancer: implications for tumour progression Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers Single-step isolation of extracellular vesicles by size-exclusion chromatography Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.Cancer and Venous Thromboembolic Disease: A Review.The role of thromboprophylaxis in cancer patients: emerging data.Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance.Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006 Clues to occult cancer in patients with ischemic stroke Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer Tissue factor in tumor microenvironment: a systematic review Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays.Arterial and venous thrombosis in cancer patients Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease.Role of tissue factor in venous thrombosis.Microparticles in hemostasis and thrombosis.Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis Methodology for isolation, identification and characterization of microvesicles in peripheral blood.Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Circulating membrane-derived microvesicles in redox biology.Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.New insights into the mechanisms of venous thrombosis.Cancer and coagulation.Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.Microvesicles as potential ovarian cancer biomarkers.Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.

P2860

Q21129255-CE247806-D7E8-4036-87FE-BDA3E9AF9A32 Q24628728-F7BA07E4-4EF0-4DA8-B655-22645F43033C Q26768704-F87C1E3D-4AEE-44D2-8808-AF06260B5E3C Q26779938-77F10D58-6B85-44FB-9B8E-BB2A0B5CE6A9 Q26783691-AF4801D3-A4F4-49A7-B61A-781F76D6DC2C Q26823716-3923F795-4CE8-443C-965A-4EE3C63364F9 Q26830846-287BF7A4-3F7D-44DA-8ED8-44AF1F43D34C Q26852015-CE68D669-2C03-478C-8089-83315AA7EF51 Q26865716-8F129568-E29E-4D1B-93D3-F9ED1502BA18 Q26998742-59221544-1CBE-4907-87A3-9762971192A4 Q27023509-99B83475-765C-40D8-BFC5-DB8D87C8EF41 Q29395319-EE4F932C-1889-4D52-BF02-F8045529F927 Q33401969-B19F6CFA-C1F6-462D-8F88-0AAB41553757 Q33439089-23D6FB5C-2D1C-4B90-B12C-742245D84CD2 Q33625063-D17E5CDE-860F-41CF-B33E-492541C44330 Q33674156-9E25AE63-B16D-4E10-B87A-745B9ACBFF40 Q34080036-6BA73192-AD42-46DF-B2C9-9B5A0221AD8B Q34250240-CED7637B-FB45-4127-812F-17BF69C9A5C8 Q34416283-DD688ADE-9802-4F25-B78C-0E10CFBD5824 Q34450769-9C17E034-FD79-4181-A7FB-6EC109DC75DC Q34544801-C95736EE-C18D-4BFF-9B58-8CC948AAA412 Q34599765-A7995892-54DD-42A1-B84B-451CEF552D5D Q34635182-67261DEF-A27A-4564-8550-56762A4E2958 Q34734810-DDF79E68-319C-4A1E-B55C-9CA6AFD83C3B Q34795476-D69EF008-5DDF-44D4-AF7F-6A538BE6BB9A Q35131040-A1DBD50C-C91B-4A14-8FC2-16FE3719A917 Q35594902-DC632D0E-1756-4A05-A28E-7EF7FAC19FE8 Q35661078-308CDCBD-8C3B-4201-8097-7213E4D03544 Q35690807-F92DEA87-97C0-484A-90FF-23CD54166A86 Q35737756-A713A6AF-4812-480B-9718-F0112518EFDE Q35987865-05B978BF-1D16-4364-BEEA-29D2F7D74F83 Q36015233-E6923D14-2532-485E-9E1C-7F8FCB757DEB Q36051099-F28FF1AA-6E5F-4D9C-9695-6DDF87759664 Q36068279-EE161072-7C61-4A65-8D46-C042382AABB3 Q36391554-CDA4B6FA-6576-41AB-A7BA-8B541B89F791 Q36464075-3D0E4E50-2194-4123-AA50-668A61AA4B6C Q36470049-80358FD2-310B-4AD5-B8AD-C10268960676 Q36635032-607C6720-A930-4C2E-8BFF-8BB96A85659E Q36721696-9531B122-4961-4334-B8A8-00A9E37D5A95 Q36906388-449A14B6-5C32-4E03-8975-30180593A97A

P2860

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

http://www.wikidata.org/entity/Q37438142

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor-derived tissue factor-be ...... oembolic events in malignancy.

@en

Tumor-derived tissue factor-be ...... oembolic events in malignancy.

@nl

type

label

Tumor-derived tissue factor-be ...... oembolic events in malignancy.

@en

Tumor-derived tissue factor-be ...... oembolic events in malignancy.

@nl

prefLabel

Tumor-derived tissue factor-be ...... oembolic events in malignancy.

@en

Tumor-derived tissue factor-be ...... oembolic events in malignancy.

@nl

P1433

Q37438142-994F1A12-7A0B-4885-ABA0-7BDB388BF130

P1476

Q37438142-E3903DE5-69B8-4888-A674-43BDB76A3B79

P2093

Q37438142-4ACCE65E-BE41-4AF1-A62E-CA86949E5FDB

Q37438142-687A969A-BC5F-45C8-9F35-DDFEB40E1955

Q37438142-6E36C0ED-AA7F-407A-8B2C-6A3B04F54E14

Q37438142-88A7C90C-B947-49BC-9453-3CBFFFECF2BE

Q37438142-DAD7E319-6AF0-4014-9158-DCE7B6D36D74

Q37438142-FDCAE770-EE8A-49B3-A05C-B2F3FB62F4C6

P2860

Q37438142-054E238A-5348-4696-9525-9C75CB3A6D9C

Q37438142-074C101B-312A-41DD-90D4-E769F8F07E79

Q37438142-07B60125-4B82-44FD-B23A-CA69AA176D48

Q37438142-081275A3-6874-4D6F-B5C6-A31325D45A89

Q37438142-0D78C633-8164-48AA-860F-7A40D596EDFA

Q37438142-178B316C-52FA-4EED-BF00-420BF21C22C5

Q37438142-37FD7F25-163E-47B2-8E5D-DB76EEE106C9

Q37438142-3DADDFB8-7762-4CD7-971E-33BCDA58FCA3

Q37438142-4133417C-3439-41C4-A452-425A0AEC720C

Q37438142-41354DEC-CDFF-455E-9DEC-A70062AF1EB0

P304

Q37438142-932117D8-02D3-4729-AB28-30F548CB143E

P31

Q37438142-8BD7354D-F31A-4FD2-8150-1D55D950E2DF

P356

Q37438142-217D5167-F462-4A9D-9826-0658B4C46599

P407

Q37438142-7BC11E49-E400-466B-8E49-0C511E10462F

P433

Q37438142-389E4306-D27B-43D5-8E03-F1690A943E9C

P478

Q37438142-BBC58890-D521-4F6C-B56A-64CDFDDAAA21

P50

Q37438142-27FC7D5F-0360-4F3A-AFF4-BFADAA6C5189

P577

Q37438142-10221EDA-5E4D-44AC-B2D2-5A052F5CEE82

P5875

Q37438142-17D9110B-3A1D-4ADC-9597-8A73C2058755

P698

Q37438142-BB1C04A1-EB7F-48A9-B362-053EA1FBAB9A

P921

Q37438142-E4627FC6-0E61-464E-B779-EA76FDC3D80F

P932

Q37438142-1E6EA350-7B53-4AC5-98AA-623D345B2554

P356

1078-0432.CCR-09-0371

P1433

Clinical Cancer Research

P1476

Tumor-derived tissue factor-be ...... boembolic events in malignancy

@en

P2093

Barbara C Furie

http://www.w3.org/2001/XMLSchema#string

Bruce Furie

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Howard A Liebman

http://www.w3.org/2001/XMLSchema#string

Kenneth A Bauer

http://www.w3.org/2001/XMLSchema#string

Romaric Lacroix

http://www.w3.org/2001/XMLSchema#string

P2860

Trousseau's syndrome: multiple definitions and multiple mechanisms

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.

Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.

Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation.

Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies.

Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.

Thrombosis and cancer.

P304

6830-6840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-0371

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey I Zwicker

P577

2009-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38040652

http://www.w3.org/2001/XMLSchema#string

P698

19861441

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

P932

2783253

http://www.w3.org/2001/XMLSchema#string